iiinova — where your digital self keeps evolving

Estelamari Rodríguez @latinamd.bsky.social · 29/05/2025

In just 2 days, join us during #ASCO25 for a special session on "Leveraging Social Media for Your Career" with @marklewismd ▶️ Finding your voice (among all the noise) ▶️ Expand your network ▶️ Promote your research 📆 Friday, May 30th ⏰ 3:00-3:45PM 📍Hall C, ASCO Trainee Lounge @ASCOTECAG

010

Estelamari Rodríguez @latinamd.bsky.social · 15/05/2025

So many abstracts so little time⌚! Here are #ASCO25 Top Lung Cancer Abstract Presentations to watch for -Part 1 Not a lot of new drugs but important updates on #perioperative and #targetedtherapy trials. Full abstracts available 5/22. #lcsm @hemoncfellows @hemoncmiami @sylvestercancer

061

Estelamari Rodríguez @latinamd.bsky.social · 13/05/2025

#ASCO25 Top Lung Cancer Abstract Presentations to watch for Trainees (a working list) Updates on #perioperative and #targetedtherapy trials. #CM77T #CM816, #NEOADAURA, #ALNEO, #SACHI, #KRYSTAL-2 #lcsm @hemoncfellows @hemoncmiami @sylvestercancer

000

Estelamari Rodríguez @latinamd.bsky.social · 12/05/2025

3️⃣ Weeks to go to #ASCO25 !. The schedule can be so overwhelming.. Here is my suggested schedule for thoracic trainees. Start making your schedule in the @asco app today and bring comfortable 👟 @hemoncfellows @hemoncmiami #lcsm

021

Estelamari Rodríguez @latinamd.bsky.social · 09/04/2025

#ASCOAdvocacySummit Walked 14,000 steps today to visit the offices of 2 senators & 4 Representatives in Congress with the awesome delegation of oncologists from FL to advocate for #NIHFunding #cancerresearch #priorauthorization #drugshortages #physicianadvocates @ascocancer @sylvestercancer

030

Estelamari Rodríguez @latinamd.bsky.social · 07/04/2025

Thank you, @ASCO for naming me an Advocacy Champion at the #ASCOAdvocacySummit. I am proud to advocate on issues important to our patients like #PriorAuth #CancerResearch #NIHFunding #DrugShortages Looking forward to impactful conversations at Capitol Hill tomorrow! @SylvesterCancer

061

Estelamari Rodríguez @latinamd.bsky.social · 07/04/2025

#ASCOAdvocacySummit learning from @ASCO experts on the hurdles and process to get #PriorAuthorizationBill created and why it takes yrs to get things done. Our cancer pts can’t afford delays #FixPriorAuthorization

030

Estelamari Rodríguez @latinamd.bsky.social · 07/04/2025

#ASCOSAdvocacySummit Capitol Hill Legislative Trainning this morning. Florida delegation ready to speak to legislators about @ASCO bipartisan priorities: ✅NIH Cancer Research ✅Prior Authorization Bill ✅Cancer Drug Shortages #physicianadvocates #beatthetable

000

Estelamari Rodríguez @latinamd.bsky.social · 07/04/2025

#ASCOAdvocacySummit starting today with remarks by @RepHerbConaway MD. Honored to be here representing FL oncologists to advocate for issues that impact our patients and field. #patientadvocacy @ascocancer.bsky.social @sylvestercancer

021

Estelamari Rodríguez @latinamd.bsky.social · 31/03/2025

Best #HappyDoctorsDay 🎉gift celebrating 4 years NED scans after ChemoIO induction and pneumonectomy for locally advanced lung cancer with my patient @SylvesterCancer 👉🏽see patient story in Spanish here: youtu.be/N7SZ2iNfP8g #lcsm

020

Estelamari Rodríguez @latinamd.bsky.social · 27/03/2025

The MARIPOSA effect 🦋 ‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25 🎯OS HR 0.75 (95%CI: 0.61-0.92) 🎉> 1 yr mOS advantage 🚫no crossover allowed, ⬆️intracranial activity ⬇️toxicity over time w prophylactic mgmt (skin) #lcsm

0102

Estelamari Rodríguez @latinamd.bsky.social · 22/03/2025

If you could make it (your argument) there, you’ll make it anywhere 🎵 Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer

130

Estelamari Rodríguez @latinamd.bsky.social · 22/03/2025

🚨 A must read as more younger people get diagnosed with cancer: Updated @ASCO Guidelines on Fertility Preservation in People With Cancer: | Journal of Clinical Oncology buff.ly/BFpFrw8 ➡️ fertility preservation options for men/women/children ➡️ established and emerging methods discussed

034

Estelamari Rodríguez @latinamd.bsky.social · 11/03/2025

Thrilled to speak this Thursday at the @TotalHealthConf Lung/GI #CancerUpdates with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews 🗓️ Thu, March 13thm 5:0PM-8:00PM 📍 Trump International Resort, Sunny Isles FL @sylvestercancer #lcsm

010

Estelamari Rodríguez @latinamd.bsky.social · 09/03/2025

On #InternationalWomensDay, we celebrate all the contributions of #womeninmedicine .Let’s keep supporting women and give them the recognition they deserve in faculty and leadership positions. #WomenLead

031

Estelamari Rodríguez @latinamd.bsky.social · 08/03/2025

We had a great time this morning @go2forlungcancer Hollywood 5K 🏃‍♂️ Run/ Fly Kite🪁 to raise awareness about #lungcancer and support our patients and caregivers. #lcsm @sylvestercancer

000

Estelamari Rodríguez @latinamd.bsky.social · 07/03/2025

Join the @sylvestercancer team tomorrow for the @GO2forLungCancr 11th annual Hollywood 5K Walk/Run & Kite Fly! Supporting #lungcancer research and patient services 📆Saturday, March 8, 2025 ⏰ 8AM 📍 Hollywood North Beach Park 👉🏽Support our team here: buff.ly/bj3gO3l #lcsm

000

Estelamari Rodríguez @latinamd.bsky.social · 02/03/2025

🔥🔥Off the press Updated @ASCO Living Guidelines on Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations, Version 2024.3 ▶️ Discussion of 2nd line options ▶️ Update on T-Dxd for HER2 IHC3+ lungcancer ▶️ No consensus on use of TTF, Dato-DXd 👉🏽 ascopubs.org/doi/10.1200/...

011

Estelamari Rodríguez @latinamd.bsky.social · 27/02/2025

🌍 #WCLC2025 @iaslc Where Innovation Meets Collaboration! 📅 Sept 6–9, 2025 | Barcelona. 🔹 Registration & Abstract Submission OPEN! Join top experts & rising stars to shape the future of lung cancer care. 🔗 Register/Submit: bit.ly/IASLCWCLC #WCLC25 #LungCancer #lcsm

bit.ly

Home - WCLC 2025

Join us at the IASLC 2025 World Conference on Lung Cancer (WCLC 2025) in Barcelona, Spain, from September 6–9, 2025.

030

Estelamari Rodríguez @latinamd.bsky.social · 26/02/2025

Shape the future of thoracic cancer care & nominate yourself or a colleague for an #IASLC @iaslc committee. Diverse voices drive innovation! Apply: bit.ly/IASLCNoms #lcsm 📅 Deadlines to nominate/accept: 👥 Colleague: 3/10/25 🙋 Self: 3/12/25

030

Estelamari Rodríguez @latinamd.bsky.social · 26/02/2025

🔥 Top 10 Most Cited JTO Articles of 2024! From groundbreaking discoveries to practice-changing research, these studies are shaping the future of thoracic oncology. Dive into the most impactful papers of the year! buff.ly/3CX2sE9 @JTOonline @IASLC @OncologyAdvance #LCSM

010

Estelamari Rodríguez @latinamd.bsky.social · 16/02/2025

Challenging myself trainnning with a weighted vest for the @tacklecancer #DCCXV run in support of #cancerresearch @sylvestercancer. Support my team at 👉🏽: dolphinscancerchallenge.com/participant/...

031

Reposted by Estelamari Rodríguez

Ian Carrillo @iansociologo.bsky.social · 16/02/2025

To counter the claim that diversity hires were endemic, here's an example. A year after I was hired at my institution (an R1 state flagship), I was one of two (2) Latine assistant professors on the entire campus. I alone represented 50% of Latine assistant profs. How could this be DEI run amok?

1133445

Estelamari Rodríguez @latinamd.bsky.social · 12/02/2025

👏👏👏@ASCO for promoting equitable career advancement & leadership opportunities (i.e. DEI) in new Recommendations for Academic Medical Centers-Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists ascopubs.org/doi/10.1200/...

010

Estelamari Rodríguez @latinamd.bsky.social · 11/02/2025

Great work by @Tony_Calles and 🇪🇸 investigators on #LUPER Ph1/2 #Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC). N=28, no prior IO Better OS on platinum sensitive -15.7 vs 7 mos jto.org/article/S1556-…

000

Estelamari Rodríguez @latinamd.bsky.social · 09/02/2025

🏃🏽‍♀️Sunday run trainning for the #DCCXV Dolphins Challenge Cancer in just 2️⃣ weeks @TackleCancer run to support #cancerresearch @sylvestercancer . Support my team at 👉🏽 buff.ly/4gCE2xg

020

Estelamari Rodríguez @latinamd.bsky.social · 06/02/2025

😔 Grief is forever. Great talk today on Grief-Informed Care in the Cancer Setting by Wendy G. Lichtenthal, Ph.D @sylvestercancer. So much that we can do to support patients, caregivers & healthcare providers facing grief. #physicianwellness #griefcounseling #cancersupport

082

Estelamari Rodríguez @latinamd.bsky.social · 05/02/2025

IASLC Reviewer Workshop 2025 OPEN for Applications! Calling early & mid-career professionals (within 15 years of training) in Europe, Africa, & the Middle East! Apply now for this prestigious opportunity. Deadline: April 1, 2025🔗https://buff.ly/40OpPHS #LCSM

020

Estelamari Rodríguez @latinamd.bsky.social · 05/02/2025

Catch the new episode of #LungCancerConsidered as @NarjustFlorezMD & @samsonpp discuss the recent FDA approval of osimertinib after chemo-radiation in EGFR-positive #NSCLC, based on the LAURA trial. 🔗 Listen now: buff.ly/3WS6HYb #LCSM #EGFRpositive #LAURAtrial @ialsc

031

Estelamari Rodríguez @latinamd.bsky.social · 05/02/2025

Behind every cancer diagnosis is a unique human story—stories of resilience, grief, hope, and healing. People-centred care means seeing the whole person and meeting their unique needs with compassion and empathy. #WorldCancerDay #UnitedByUnique @worldcancerday @sylvestercancer

020

Estelamari Rodríguez @latinamd.bsky.social · 04/02/2025

World Cancer Day is a reminder to come together to take action against cancer. Commemorating this day @sylvestercancer Experimental Therapeutics Clinic w a team dedicated to patient-centered #cancerresearch. #WorldCancerDay @sylvestercancer

030

Estelamari Rodríguez @latinamd.bsky.social · 04/02/2025

Like many #WomeninMedicine I had a crazy Monday balancing work & home responsibilities yesterday to celebrate #NationalWomenPhysiciansDay but today I want to honor the contributions, achievements, friendships of #WomeninMedicine @HemOncWomenDocs #lcsm #WomeninThoracicOncology

051

Estelamari Rodríguez @latinamd.bsky.social · 04/02/2025

010

Estelamari Rodríguez @latinamd.bsky.social · 01/01/2025

2024 was a year of learning and making connections. I am privileged to have met so many amazing researchers all over the world who are passionate about finding better treatments for patients. #conferencing #2024review @SylvesterCancer #lcsm

030

Estelamari Rodríguez @latinamd.bsky.social · 18/12/2024

🚨New Years Resolutions : Learn a new 🫁9th #lungcancer staging system In this episode of #LungCancerConsidered, host @StephenVLiu & guests preview the adoption of the IASLC 9th Edition of the TNM Classification for #lungcancer. The new version will be published by Jan 2025 #LCSM

030

Estelamari Rodríguez @latinamd.bsky.social · 18/12/2024

This is disappointing. I thought we would have #amivantamab subq formulation for EGFR+ #lungcancer for Xmas, which could make drug delivery easier, but @FDAOncology says not yet. Update on U.S. regulatory review of subcutaneous amivantamab #lcsm www.jnj.com/media-center...

jnj.com

Update on U.S. regulatory review of subcutaneous amivantamab

020

Estelamari Rodríguez @latinamd.bsky.social · 14/12/2024

Thank you @JaimeMerchan10 for opening your home for a lovely brunch to celebrate our growing Phase 1/ Experimental Therapeutics team @SylvesterCancer #researchmatters #TeamScience

030

Reposted by Estelamari Rodríguez

Eric Topol @erictopol.bsky.social · 12/12/2024

How insurance companies degrade the patient-doctor relationship, by Helen Ouyang, my friend and exceptional physician-author gift link www.nytimes.com/2024/12/08/o... @nytopinion.nytimes.com

28466176

Reposted by Estelamari Rodríguez

Yvonne Diaz @yvonnediaz.bsky.social · 11/12/2024

Many in our #lungcancer community wonder if the max or same dose is right for everyone. Great study out of the NL looking at this issue in ALK+ lung cancer. Perhaps lead to personalized dosing in future. Thank you for sharing @drjnaidoo.bsky.social and @jtoonline.bsky.social #LCSM

152